CANCER PREVENTION AND CONTROL PROGRAM The UNC Lineberger Cancer Prevention and Control Program focuses on the development, evaluation, and dissemination of evidence-based interventions and policy approaches to improve cancer outcomes in North Carolina and beyond. Our program is comprised of 56 program members and fosters strong collaborations between faculty from the six schools; Schools of Medicine, Public Health, Nursing, Pharmacy, Media and Journalism, and the College of Arts and Sciences and 28 departments. The CPC program has four broad themes: (1) Implementing health promotion interventions to reduce cancer risk factors; (2) Developing cancer communication strategies to improve cancer prevention and control; (3) Improving quality of cancer care and long-term outcomes for cancer survivors; and (4) Studying patterns of cancer care, screening, and prevention to inform interventions and policy initiatives that improve cancer outcomes. Eliminating cancer health disparities is a cross-cutting theme of our program. Highlights of our nationally recognized research by program investigators include: tobacco control policy research on the design and efficacy of graphic cigarette warning labels that is guiding FDA policy; research on sales and marketing of electronic cigarettes, including interventions to prevent adolescent e-cigarette use; research on digital and mobile interventions for diet, obesity, physical activity, and symptom management with particular focus on disadvantaged populations and cancer survivors; novel patient-reported outcomes studies that inform national policy; and implementing interventions in our Catchment area of North Carolina focused on eliminating disparities in access and outcomes. The Program is led by Dr. Kurt M. Ribisl, a behavioral scientist, and Dr. Ethan Basch, a medical oncologist and health services researcher. Program members are PIs of three NCI funded pre- and post-doctoral training grants. The Program adds value in terms of integrative activities and opportunities for intra- and cross-program collaboration; professional development and networking support for junior faculty CPC members; access to shared resources such as the Communications for Health Applications and Interventions, Biostatistics, and Patient-Reported Outcomes Core; as well as space, seminars, retreats, training, and education. Since our last renewal, UNC Lineberger has benefited the Program through strong support for infrastructure, faculty recruitments, extensive use of shared resources, and providing developmental funds as befits one of three major UNC Lineberger strategic directions, ?Optimizing Cancer Outcomes in North Carolina.? During the last funding period, program members have published 1359 cancer-related articles, 26% were intra-programmatic and 19% were inter-programmatic (38% collaborative). In 2019, our program members held grants totaling $18.9M (direct cost) in cancer-relevant extramural funding, including $6.8M (direct costs) from the NCI and $8.9M in other peer-reviewed funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089818
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mayer, Deborah K; Landucci, Gina; Awoyinka, Lola et al. (2018) SurvivorCHESS to increase physical activity in colon cancer survivors: can we get them moving? J Cancer Surviv 12:82-94
Huo, Dezheng; Perou, Charles M; Olopade, Olufunmilayo I (2018) Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening-Reply. JAMA Oncol 4:883-884
Howe, Chanelle J; Robinson, Whitney R (2018) Survival-related Selection Bias in Studies of Racial Health Disparities: The Importance of the Target Population and Study Design. Epidemiology 29:521-524
Byrne, James D; Yeh, Jen Jen; DeSimone, Joseph M (2018) Use of iontophoresis for the treatment of cancer. J Control Release 284:144-151
Wilkin, Timothy J; Chen, Huichao; Cespedes, Michelle S et al. (2018) A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298. Clin Infect Dis 67:1339-1346
Siegel, Marni B; He, Xiaping; Hoadley, Katherine A et al. (2018) Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest 128:1371-1383
Ubil, Eric; Caskey, Laura; Holtzhausen, Alisha et al. (2018) Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest 128:2356-2369
Hamad, Ahmad; Iweala, Onyinye I; Henderson, Cory et al. (2018) Recurrent anaphylaxis during cardiac catheterization due to ethylene oxide. J Allergy Clin Immunol Pract 6:2148-2150
Ho, G-T; Aird, R E; Liu, B et al. (2018) MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunol 11:120-130
Pearce, Oliver M T; Delaine-Smith, Robin M; Maniati, Eleni et al. (2018) Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers. Cancer Discov 8:304-319

Showing the most recent 10 out of 1525 publications